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Contribution of Cholinergic and GABAergic Mechanisms to
Direction Tuning, Discriminability, Response Reliability,
and Neuronal Rate Correlations in Macaque Middle
Temporal Area
Alexander Thiele,1 Jose L. Herrero,1 Claudia Distler,2 and Klaus-Peter Hoffmann3
1Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, NE1 7RU, United Kingdom, and 2General Zoology and Neurobiology and 3Animal
Physiology, Ruhr University Bochum, D-44801 Bochum, Germany
Previous studies have investigated the effects of acetylcholine (ACh) on neuronal tuning, coding, and attention in primary visual cortex,
but its contribution to coding in extrastriate cortex is unexplored.Herewe investigate the effects of ACh on tuning properties ofmacaque
middle temporal areaMTneuronsandcontrast themwitheffects of gabazine, aGABAAreceptorblocker.ACh increasedneuronal activity,
it had no effect on tuning width, but it significantly increased the direction discriminability of a neuron. Gabazine equally increased
neuronal activity, but it widened tuning curves and decreased the direction discriminability of a neuron. Although gabazine significantly
reduced response reliability, ACh application had little effect on response reliability. Finally, gabazine increased noise correlation of
simultaneously recorded neurons, whereas ACh reduced it. Thus, both drugs increased firing rates, but only ACh application improved
neuronal tuning and coding in line with effects seen in studies in which attention was selectively manipulated.
Introduction
Acetylcholine (ACh) contributes to cognitive functions, such as
attention, learning, and memory, but its actions at the neuronal
level in vivo remain poorly understood. Most in vivo studies have
investigated effects of ACh in early sensory cortex (Sillito and
Kemp, 1983; Metherate et al., 1988a,b). In primary visual cortex
V1 of anesthetized cats, ACh increases neuronal orientation and
direction selectivity (Sillito and Kemp, 1983; Sato et al., 1987). In
V1 of anesthetized marmoset monkeys, ACh did not improve
orientation tuning (Zinke et al., 2006), but it sharpened spatial
tuning (Roberts et al., 2005). The latter mimics effects of atten-
tion on spatial integration properties in area V4 (Reynolds et al.,
1999), V1 (Roberts et al., 2007), and middle temporal area MT
(Womelsdorf et al., 2006). ACh application also increased V1
contrast sensitivity (Disney et al., 2007), again mimicking effects
of attention (Williford and Maunsell, 2006; Thiele et al., 2009).
Similarities between effects of attention and ACh application
continue in the domain of response reliability and firing rate
correlations. Attention reduces the firing rate variability of V4
andMTneurons (Mitchell et al., 2007; Niebergall et al., 2011), an
effect also seen in rat V1 after basal forebrain stimulation (Goard
and Dan, 2009). Attention reduces neuronal noise correlations
(Cohen and Maunsell, 2009; Mitchell et al., 2009), an effect also
induced by increasing cholinergic drive in rat visual cortex
(Goard and Dan, 2009). Finally, ACh contributes to attentional
modulation in macaque V1 (Herrero et al., 2008).
Although the effects of ACh on V1 activity are fairly well stud-
ied, the effects on tuning in extrastriate cortex are unknown.
Cholinergic receptor distribution on different cells varies be-
tween V1 and V2 (Disney et al., 2006). Therefore, extrapolation
of the role of ACh in V1 to higher cortical areas might be mis-
leading. It is thus essential to study its role in extrastriate and
higher cortical areas. Area MT is part of the extrastriate cortex in
which basic tuning properties (Maunsell and Van Essen, 1983;
Albright, 1984; Movshon et al., 1985; Britten et al., 1992), as well
as cognitive influences, such as attention (Treue and Maunsell,
1996; Cook and Maunsell, 2002; Martínez-Trujillo and Treue,
2002), decision making (Britten et al., 1992, 1996; Thiele et al.,
1999; Thiele andHoffmann, 2008), orworkingmemory (Bisley et
al., 2004; Zaksas and Pasternak, 2006), are well studied.
Wemeasured the effects of AChondirection tuning, neuronal
discrimination abilities, rate variability, and noise correlation.
We compared the effects with those seen when GABAA receptors
were blocked by gabazine, to account for effects of ACh that could
be a consequence of increased firing rates, but also to revisit the
role of GABAergic mechanisms in directional tuning using a
more specific GABAA receptor antagonist than used previously
(Thiele et al., 2004). ACh and gabazine increased firing rates, but
only ACh enhanced the ability of a neuron to discriminate be-
tween differentmotion directions.Moreover, ACh reduced noise
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correlations, whereas gabazine increased them. Many of the ef-
fects seen with ACh application were thus comparable with the
effects induced by selective attention.
Materials andMethods
All procedures were performed in accordance with the German Animal
Welfare Act of July 26, 2002, the European Communities Council Direc-
tive RL 2010/63/EC, the National Institutes of Health Guidelines for the
Care and Use of Animals for Experimental Procedures, and the United
KingdomAnimals Scientific ProceduresAct. In the present investigation,
two adult anesthetized macaques (Macaca mulatta of either sex) were
used.
Anesthesia and analgesia
The animals were premedicated with 0.04 mg/kg atropinsulfate. Ini-
tial anesthesia was induced by injection of ketamine hydrochloride
(10 mg/kg, i.m.). An intravenous catheter was placed into the saphe-
nous vein, and a bolus of 3 g/kg fentanyl was given for analgesia.
Animals were then continuously infused for the entire experiment
with 3 g  kg1  h1 fentanyl to maintain analgesia and support anes-
thesia. Animals were intubated [local anesthesia treatment with prilo-
cainhydrochlorid (Xylonest spray)] through themouth. Local anesthesia
was applied to the ears [0.5% bupivacainhydrochloride (Bupivacain)],
and animals were placed in a stereotaxic apparatus. During surgery, they
received additional doses of pentobarbital as needed. Animals were arti-
ficially ventilated with nitrous oxide: oxygen at a 3:1 ratio containing
0.2–0.7% halothane to maintain anesthesia. Heart rate, oxygen satura-
tion, blood pressure, body temperature, and end-tidal CO2 were moni-
tored and kept at physiological levels. A craniotomy was performed
according to stereotaxic coordinates to allow access to cortical area MT.
Area MT was then localized electrophysiologically according to its ste-
reotaxic position and characteristic preference to stimulus movement.
After all surgical procedures were completed, the animals were paralyzed
with 0.1mg  kg1  h1 vecuroniumbromide (Norcuron), and anesthe-
sia and analgesia were maintained as described above. At the end of the
experiments, the animals were killed with an overdose of pentobarbital
and perfused through the heart. Details of the perfusion and histological
procedures have been given previously (Distler and Hoffmann, 2001).
The location of the recording sites in areaMTwas verified in histological
sections stained for cytoarchitecture and myeloarchitecture.
Visual stimulation
A cathode ray tube (CRT) monitor (resolution of 1600 1200 pixels at
75Hz) was placed at a distance of 53 cm from the animal to display visual
stimuli under computer control. Initially, the receptive field (RF) of each
neuron was mapped by moving a bar across a reflective sheet that was
placed directly in front of the monitor. The bar was produced by a hand-
held lamp, and it allowed to map the RF location and borders, while its
motion also served to get an initial impression of the presence or absence
of direction selectivity of the recorded ensemble activity (by auditory
inspection). The size of the bar could be adjusted in length and width,
and its luminance was20 cd/m2 against a background of1 cd/m2. If
this initial assessment yielded good ensemble spiking activity and the
subjective assessment of the spike amplitudes suggested that follow on
“offline” spike sorting (see below) would yield good single-unit data, we
progressed as follows. After removal of the reflective sheet, direction
selectivity and directional tuning in the presence and absence of drug
application was determined by presenting computer-generated sine-
wave gratings (4 Hz, 0.5 cycles/°) on the CRT screen. The grating moved
along 12 different directions within a circular aperture of a size that
matched the ensembleRF size. For the first 500ms of each trial, the screen
was homogenously gray (21 cd/m2). Thereafter, the moving stimulus
was presented for 760 ms. Stimulus contrast tested was 12.5 and 25%
(Michelson contrast).We used these two contrasts tomeasure the effects
of drug application at a contrast that is usually saturating or close to
saturating (25%) and one contrast that is likely to be nonsaturating
(12.5%) in anesthetized animals. Although 12.5% contrast can be a sat-
urating contrast for neurons in awake macaque MT (Thiele et al., 2000),
it does not seem to be the case in all awake studies (Heuer and Britten,
2002) or in anesthetized animals (Kohn and Movshon, 2003). Monitor
luminance was measured with a Spectrascan PR 650 (Photo Research),
and the mapping between graphics board red–green–blue output to
monitor luminance was gamma corrected. Different stimulus direc-
tions and contrasts were presented randomly interleaved, while en-
suring that all stimuli were presented equally often during each
recording session. Stimulus presentation and data acquisition were
under the control of Remote Cortex 5.95 (Laboratory of Neuropsy-
chology, National Institute for Mental Health, Bethesda, MD) inter-
linked with Cheetah (Neuralynx).
Recordings and drug application
Recordings were performed with tungsten-in-glass electrodes flanked by
two pipettes (Thiele et al., 2006). Neuronal activity was recorded with
Neuralynx preamplifiers and amplifiers. Raw activity was bandpass fil-
tered between 600 and 9000Hz.During the recording sessions, these data
were thresholded to obtain multiunit activity, and the resulting spike
waveforms were sampled at 30 kHz. To obtain single-unit data, offline
sorting was performed based on the stored spike waveforms, using Neu-
ralynx Spikesort3D software. All data reported here were performed
based on offline-sorted spikes.
During the recording session, one pipette was filled with ACh and the
other with gabazine, which were iontophoretically applied (NeuroPhore
BH-2; Digitimer). Pipette opening diameter varied between 1 and 4m.
Pipette resistance varied between 10 and 150 M, with most recordings
at 20–80 M. Hold currents during control and recovery were usually
10 nA; in rare occasions (when the pipette resistance was 10–20 M),
it was 40 nA. Pipette–electrode combinations were inserted into MT
without the use of guide tubes. The integrity of the electrode and the
pipettes were checked under the microscope before and after the record-
ing sessions, in addition tomeasurements of the pipette impedancemade
before and after the recording at each recording site. All drugs were
obtained from Sigma. The details regarding drug concentration, pH, and
application current were as follows: ACh, 0.1 M, pH 4.5, application
current at 5–50 nA, withmost recordings at 5–30 nA; gabazine, 3mM, pH
3, application current at 5–40 nA, with most recordings at 5–30 nA.
Because of the range of conditions used (12 directions, two contrasts)
and the two drugsmeasured, we did not obtain a dose–response curve for
our neurons. Measuring dose–response curves (including additional
washout periods) would have required extensive periods of time, during
which cell isolation could deteriorate. Our aim was to keep the drug
effects within relatively moderate limits (avoiding tripling or even dou-
bling of firing rates if possible). We thus usually set our ejection currents
to comparatively low levels, which were based on our experience from
previous investigations (Thiele et al., 2004; Roberts et al., 2005; Zinke et
al., 2006; Herrero et al., 2008). These currents resulted in drug-induced
effects that weremore limited than those reported in other studies (Sillito
and Kemp, 1983; Sato et al., 1987; Roberts et al., 2005; Zinke et al., 2006;
Disney et al., 2007; Katzner et al., 2011), in which ejection currents were
often higher (range of 0–160 nA, most ejection currents 40 nA), but
they were in the range of those currents used in a recent study in V1
(Soma et al., 2012). We reported previously that “small” ACh ejection
currents (5–20 nA) were necessary to enhance cognitive effects in awake
primates (Herrero et al., 2008), whereas large currents can be detrimen-
tal. It is unclear how this relates to the anesthetized preparation, but we
nevertheless aimed to investigate how “moremoderate” drug effects alter
MT response properties. Specifically, we initially set the ejection current
for each recording to anywhere between 10 and 50 nA,mostly between 10
and 30 nA. If, during the initial wash-in period, the spontaneous or
stimulus-driven activity appeared to increase (or decrease) toomuch (by
visual and auditory inspection of online-monitored thresholded ensem-
ble activity of approximately two to five neurons), we reduced the ejec-
tion current by 5–10 nA. If the activity was still increased (or decreased)
too strongly (by visual and auditory inspection) after 1–2 min, we re-
duced the current by another 5–10 nA. If no changes occurred during this
initial wash-in period, we increased the ejection current by 10–20 nA. In
most cases, we did not need to change the initially chosen current. In case
epileptiform activity occurred (visual and auditory inspection), we
would immediately reduce the application current by at least 20–30 nA.
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We initially recorded the neuronal activity in the absence of ACh (or
gabazine) for 10–15 trials per condition (5min duration), followed by
a 1–5 min “wash-in” time after the drug was turned on, followed by a
recording (10–15 trials per condition) in the presence of ACh (or gaba-
zine) (5min duration), followed by one to two recordings (10–15 trials
per condition), which was started after a 5 min waiting period (“wash-
out”; because recovery usually occurs with a slight delay). Note that the
criterion to increase or decrease the amount of drug appliedwas based on
online-monitored ensemble activity, whereas the data reported here are
based on offline-sorted spikes from single neurons. Because of this dif-
ference, effects of the drug that were discernible at the level of ensemble
activity online did (in a few cases) not result in significant drug effects in
single cells as reported in Results (see Table 1). If the activity was still
stable, the above sequence was followed to record in the absence and
presence of the drug (ACh or gabazine) that was not used in the first
round of applications.We randomly alternated the order of the drug that
was applied first. We regularly compensated for the change in current
during the ejection condition by increasing the hold current of one of the
two pipettes, thereby keeping the overall current identical between the
“hold” and “eject” conditions.
Data analyses
Basic analysis for inclusion/exclusion of neurons.We split our data analysis
into different analysis windows (for details, see below). For each of these
windows, we determined whether the activity was stable over the course
of the recording, i.e., whether or not “drifts” occurred. The presence of
activity drifts over time was investigated by determining the firing rate
associated with stimuli moving in the preferred direction (PD) (defini-
tion see below) for each trial and calculating a Pearson’s correlation
coefficient of rate versus trial number for these data (separately at 25 and
12.5% contrast and for the drug/no drug condition 4 conditions). If a
significant correlation (p 0.0125, four conditions corrected for multi-
ple comparisons at p  0.05) was detected, a drift was considered to be
present and the data were not analyzed further (i.e., only “drift-free” cells
are included in the data presented here; first step of neuronal exclusion).
For those cells that were considered drift free, we tested whether drug
application (drug vs no-drug), motion direction (12 directions), and
stimulus contrast (25 vs 12.5%) significantly affected neuronal activity
(three-factor ANOVA, p 0.05). This was done separately for each of the
analysis windows (see below). Neurons were excluded if they were not
affected by the drug during spontaneous activity (rank-sum test, p 
0.05) or during the stimulus-driven activity (three-factor ANOVA, p 
0.05 mentioned above) (second step of neuronal exclusion). The
stimulus-driven firing rate ANOVA analysis takes account of firing rates
associated with any of the 12 different stimulus directions and both con-
trasts. Thus, it was not simply an assessment of drug effects on PD activ-
ity. Drug effects on PD activity were analyzed separately using a post hoc
two-sided t test (p 0.05). A drug effect on stimulus-driven activity was
considered to be present if the three-factor ANOVA showed a significant
main effect of drug, a significant interaction between drug and contrast,
a significant interaction between drug and direction, or a significant
triple interaction between drug, contrast, and direction (p 0.05). The
ANOVA was calculated based on stimulus-driven firing rates after sub-
traction of spontaneous activity (spontaneous activity was calculated and
subtracted separately for the drug and non-drug condition). Note that, if
a neuron was tested with ACh and gabazine but, for example, only gaba-
zine induced significant changes, then the neuron was included in the
gabazine sample but not the ACh sample. If only ACh resulted in signif-
icant changes, then the opposite would apply. For neurons that were
significantly affected by a drug and by the stimulus direction, we deter-
mined the PD. In our definition, the PD corresponded to the direction of
motion that yielded the largest response in the absence of drug applica-
tion at a stimulus contrast of 25% within the time period of interest (see
below). We next determined whether the maximum firing rate of a neu-
ron within the analysis window exceeded the spontaneous activity by5
spikes/s. If not, the neuron was not analyzed further (third step of neu-
ronal exclusion). Finally, we calculated the activity for motion in the PD
and the anti-preferred direction (APD; definitions are given below).
From those two measures, we calculated the direction index (DI): DI
1  APD/PD (baseline activity subtracted). Neurons with a DI  0.5
were excluded from additional analysis (fourth step of neuronal exclu-
sion). Our exclusion steps were performed consecutively, i.e., we only
analyzed drug effects, if a cell did not show drifts. We only determined
whether activity levels with PD motion were 5 spikes/s above sponta-
neous activity, if a drug effect was present.We only analyzed whether the
DI 0.5 if the firing rate criterion had been positively assessed. Thus, the
cell numbers listed in Table 1 are based on consecutive exclusion.
Analysis of responses in different time windows. For each neuron, we
determined the latency separately for 25 and 12.5% contrast, by con-
structing the peristimulus time histogram (PSTH) in 1 ms bins,
smoothed with a Gaussian kernel of   10 ms. We then selected the
PSTH that showed the highest activity and identified the first of 15 con-
secutive bins, in which the activity exceeded the mean spontaneous ac-
tivity more than three times the SD of the spontaneous activity. The time
of the first bin fulfilling this criterion was taken to be the neuronal la-
tency. We then calculated the neuronal activity, tuning, and d (see be-
low) in two different response windows. The first window ranged from 0
to 150 ms after response onset and captures the response transient asso-
ciated with stimulus onset. The second response window ranged from
150 to 550 ms after response onset and corresponds to the sustained
neuronal response. We used these two windows for two reasons. Our
previous investigation had shown that GABA blockade affected direction
selectivity mostly during the early response transient. Moreover, various
studies have shown that cognitive effects on neuronal activity are more
pronounced during the sustained (later) response period (Roelfsema et
al., 1998; Reynolds et al., 2000; Roberts et al., 2007) (but see Ghose and
Maunsell, 2002). As an additional control, we analyzed our data within
fixed time windows that were set to cover the periods from 50 to 200 and
200 to 700 ms after stimulus onset. This control serves to determine
whether a drug effect is invariant to the time after stimulus onset.
Within these defined response windows (whether related to neuronal
response onset or related to stimulus onset), we determined the direction
of motion that yielded the maximum activity (at 25% contrast) and
defined this direction as the PD. We defined the direction of motion
opposite to PD to be the APD.
Analysis of directional tuning in the presence and absence of
drug application
Effect of drug application on firing rates.We calculated firing rates during
spontaneous activity (i.e., while only the homogenous gray background
was presented) and during two different time windows after response
onset when the PD of motion was presented (0–150 and 150–550 ms
after response onset, respectively). This was done separately for 12.5 and
25% contrast stimuli and for drug-applied versus no-drug-applied data.
To test for differential effects between ACh and gabazine, we calculated a
drug modulation index (MI) according to the following:
MI 
activitydrug  activityno drug
activitydrug  activityno drug
.
MIs reported herewere based on firing rates (activity)when the preferred
motion direction was presented.
Directional tuning assessment 1. To determine “when” the drug af-
fected directionality, we calculated a time-resolved DI for each neuron at
25 and 12.5% contrast in the presence and absence of drug. We defined
the PD as described above (direction of motion that yielded maximum
activity at 25% contrast in the absence of drug) and calculated the neu-
Table 1. Number of cells included/excluded from dataset
ACh 0–150 ms ACh 150–550 ms
Gabazine
0–150 ms
Gabazine
150–550 ms
Included 52 58 76 67
Drift 18 16 12 20
No drug effect 3 2 6 4
Activity too low 6 4 12 15
No DI 1 0 2 2
Total 80 80 108 108
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ronal activity in 10 ms bins from 30 ms after stimulus onset until 480 ms
after stimulus onset for the PD and the APD (baseline activity sub-
tracted). From these activities, we calculated theDI (described above) for
each time bin. This was done separately for the different drug and con-
trast conditions, yielding four time-resolved DIs for each neuron. From
these single-neuronDIs, the time-resolved populationDIwas calculated.
A Wilcoxon’s signed-rank test was used to determine whether (and
when) the drug application had a significant effect on theDI.Weused the
Figure1. EffectsofgabazineandAChondirectiontuning intwoexampleneurons.A, Stimulus-drivenactivitywhengabazinewasappliedandwhenitwasnotapplied.B, Stimulus-drivenactivity,whenACh
wasappliedandwhen itwasnotapplied.Blue rasters, histograms, and tuningcurves inAandB showdatawhennodrugwasapplied.Red rasters, histograms, and tuningcurves showdatawhen thedrugwas
applied. Two sets of blue rasters are shown in eachhistogram (flanking the red rasters). The bottom set of rasters corresponds to the initial recording,whereas the top set corresponds to the activity associated
with the recovery recording. The dashed ellipsoid in the center corresponds to thewrappedGaussian fitting, i.e., they are the tuning curves fromwhich tuningwidth and amplitudewere extracted.
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false discovery rate (FDR) to account for mul-
tiple comparisons (Benjamini and Hochberg,
1995).We controlled for FDR to be at or below
a value of q  0.05, by first ordering our p
values: p(1) p(2) p(3)… p(n), where
n was the number of time bins. We then ac-
cepted a threshold value of p(r), where rwas the
largest i such that p(i) (i/n) q. Given that
we had 45 time bins per contrast, we would
accept significance of an effect of the drug if
at least one p value was smaller than 0.05/45.
If so, we would alter the acceptance level and
determine whether a second p value was
smaller than ]2  (0.05/45). If so, we would
alter the acceptance level again and deter-
mine whether a third p value was smaller
than 3  (0.05/45). This would be reiterated
until the nth p value was larger than n 
(0.05/45). All p values until n  1 would be
accepted as significant. In addition, we cal-
culated the DI within response windows of
50–200 and 200–700 ms after stimulus onset
and determined whether these were affected
by the drug application (Wilcoxon’s signed-
rank test, p  0.05).
Directional tuning assessment 2. To deter-
mine whether drug application affected differ-
ent aspects of the tuning curve, we calculated
the tuning width and amplitude by fitting a wrapped Gaussian function
(Swindale, 1998) to the mean response of each motion direction [ 2
fitting performed under MATLAB (MathWorks)]:
G		 
  B  A 
 
n5
n5
exp 		    180n
22 
 2 ,
whereG(	) is the predicted response given the motion direction (	), A is
the tuning amplitude,  is the bandwidth,  is the center location (the
predicted preferredmotion direction), andB is the offset. Bandwidthwas
reported as full-width at half-height (FWHH).Only neurons with70%
of variance accounted for (Carandini and Ferster, 1997) between actual
and fitted values were included into the tuning widths and amplitude
analysis. A Wilcoxon’s signed-rank test was used to determine whether
any of these tuning parameters were significantly influenced by drug
application.
Drug-effect-matched samples. During our experiments, we attempted
to adjust the drug ejection currents to yield changes in firing rate with
ACh and gabazine that were on average similar. This is difficult to
achieve, and we therefore did an additional control, in which we per-
formed the above analyses based on activity-matched samples. To do so,
we determined the PD activity under control conditions and under drug-
applied conditions for each neuron that was recordedwithACh.We then
assessed whether our gabazine sample contained neurons that had simi-
lar PD activity levels (20%) in the control condition and that had
similar drug-induced activity changes (20%). If no such neuron was
found in our gabazine sample, we excluded the neuron recorded in the
ACh experiments from the ACh sample. If at least one matching “gaba-
zine” neuron was found, we kept the ACh neuron in our ACh sample,
and we added all the matching gabazine neurons to our “ACh-matched
gabazine” sample. Given that any gabazine neuron couldmatchmultiple
ACh neurons, we ended up with larger “ACh-matched gabazine” neuro-
nal samples than “ACh samples.” To account for this discrepancy and its
possible effect on significance, we then performed sample size matching.
Here we randomly drew neurons from our “ACh-matched gabazine”
sample until we had equal sample sizes in both sets. We repeated this
procedure 10,000 times and each time calculated p values to determine
whether either drug significantly affected the DI, FWHH, and tuning
amplitude given the stimulus contrast and the analysis window of inter-
est. We then took the median p value that was determined for each
variable and took this to reflect whether the parameter of interest was
significantly affected by drug application in activity-matched neuronal
samples.
Neuronal discriminability. DIs and tuning curves do not provide in-
sight into how well a neuron can discriminate between different direc-
tions of motion, because they only measure mean responses without
taking variability into account. To assess discriminability, we calculated
neuronal d values, using the response associated with PD stimuli as a
reference.
We computed the neuronal d as follows:
d 
	1  2


with
  	n1  1
12  	n2  1
22n1  n2  2 .
1 and 2 represent the mean activity between activity associated with
motion in PD (1) and the activity associated with motion in any of the
comparator directions (2), n represents the number of trials, and2 and
1 denote the SDs of the activity.
Reliability of responses
To test whether the application of ACh/gabazine showed a systematic
effect on the trial-to-trial response reliability, we calculated the Fano
factor (FF), the ratio of spike count variance to mean spike count. We
computed the FF for the PD motion and the APD motion when ACh/
gabazine was applied and when it was not applied. This was done in a
moving time window of 50 ms length starting at 0 ms after response
onset, in steps of 50 ms until 600 ms after response onset (12 time win-
dows total).We performed a three-factor ANOVA to determine whether
the stimulus (PD, APD), the drug, or the time after stimulus onset sig-
nificantly affected the FF.
Correlation of responses between neurons
We calculated firing rate correlations (noise correlations) between
simultaneously recorded neurons by obtaining spike counts for each
trial from neurons recorded simultaneously from the same electrode
from 50 to 700 ms after stimulus onset. We then calculated a Spear-
man’s rank correlation coefficient between the trialwise spike counts
from the two neurons for each direction of motion relative to PD of
Figure 2. Effect of gabazine and ACh on spontaneous activity. A, Mean spontaneous activity when gabazine was not applied
(plotted along the x-axis) andwhen gabazinewas applied (plotted along the y-axis).B, Mean spontaneous activitywhen AChwas
not applied (plotted along the x-axis) and when ACh was applied (plotted along the y-axis). p values denote significance of drug
effects (Wilcoxon’s signed-rank test). Black squares indicate whether spontaneous activity was significantly affected by the drug,
and gray circles indicate that spontaneous activity was not significantly affected.
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neuron 1 (which was chosen arbitrarily). Given that neurons were
recorded from the same electrode and because of the columnar orga-
nization of MT, neuronal pairs included here had PDs that were
usually within 45° of one another. The small sample size (20 pairs for
ACh application, 26 pairs for gabazine application) precluded an
analysis of noise correlation for neurons with more and those with
less matching PD. Correlation coefficients were Fisher transformed
before being subjected to a three-factor ANOVA (factor 1, direction
of motion; factor 2, stimulus contrast; factor 3, drug applied/not
applied).
Figure 3. Effects of gabazine and ACh on activity (in spikes per second).A, PD activity (PD act) when gabazinewas not applied (plotted along the x-axis) andwhen gabazinewas applied (plotted
along the y-axis). B, PD activity (PD act) when ACh was not applied (plotted along the x-axis) and when ACh was applied (plotted along the y-axis). p values denote significance of drug effects
(Wilcoxon’s signed-rank test). The time window analyzed (relative to neuronal response onset) is indicated above each column. Data obtained at 25% contrast are shown in columns 1 and 2. Data
obtained at 12.5%contrast are shown in columns3 and4. Square symbols indicate that stimulus-driven activitywas significantly affectedby thedrug: black squares indicate that PDactivitywas also
significantly affected by the drug, and gray circles indicate that stimulus-driven activity was not significantly affected (but spontaneous activity was).
Figure 4. Effects of ejection current and drug type on stimulus-driven activity. A, B, Drug-induced change in activity (drug MI), plotted against the ejection current used for the two drugs, with
different contrast and analysis windows. p values show that drug MI was not significantly correlated with ejection current. C–F, Drug-induced activity changes (drug MI) for the two drugs, at
different contrasts and time windows (gray histogram, gabazine drug MI; black histogram, ACh drug MI). p values indicate whether the two distributions significantly differed. G, Example of
contrast-induced activity changes when no drug was applied (black histogram) and contrast-induced activity changes when ACh was applied (gray histogram). Time window used was 0–150ms
after neuronal response onset. PD act, PD activity.
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Results
We recorded 108 neurons during gabazine application and 80
during ACh application. As outlined in Materials and Methods,
we initially determined whether or not an activity drift had oc-
curred during the recording. For drift-free cells, we then assessed
whether the drug had a significant effect on neuronal activity
(during spontaneous or stimulus-driven activity). If so, we deter-
mined whether the cell was direction selective and whether
stimulus-driven activity in PD exceeded spontaneous activity by
5 spikes/s. Because of these selection criteria (see Materials and
Methods), we included data from 57 (0–150 ms response win-
dow) and 59 (150–550 ms response window) directionally selec-
tive MT neurons when ACh was applied (and when it was not
applied) and from 72 (0–150ms response window) and 71 (150–
550 ms response window) directionally selective MT neurons
when gabazine was applied and when it was not applied. Table 1
lists the cells thatwere excluded as a result of the exclusion criteria
outlined in Materials and Methods. RF eccentricity of cells re-
corded ranged from2 to 15°, and RF size ranged from 3 to 18°
(diameter).
Figure 1 illustrates for two example cells how gabazine and
ACh application could affect neuronal activity. Figure 1A shows
the effect of gabazine. In this example, gabazine had no signifi-
cant effect on the spontaneous activity (0.1 spikes/s without drug
vs 0.2 spikes/s with drug; p  0.05, signed-rank test), it slightly
reduced the DI (0.95 without drug, 0.91 with drug), it caused a
transient response evenwhennon-PDswere presented, especially
during gabazine application, it increased the tuningwidth (113.2°
without drug, 128.5° with drug), and it increased the tuning am-
plitude (49.3 spikes/s without drug, 64.7 spikes/s with drug). Fig-
ure 1B shows the effects of ACh application for an example cell.
Here ACh significantly increased the spontaneous activity (2.4
spikes/s without drug vs 7.4 spikes/s with drug; p 0.05, signed-
rank test). It slightly increased the DI (0.89 without drug, 0.97
with drug), it had little effect on the tuning width (62.3° without
drug, 66.2° with drug), but it increased the tuning amplitude
(38.2 spikes/s without drug, 49.5 spikes/s with drug).
Effects of ACh and gabazine on firing rates at the
population level
As described in Materials andMethods, cells were preselected on
the basis of a significant drug effect, but the sign of the drug effect
was not preselected for. Thus, in principle, increases or de-
creases (or no changes) could be seen at the population level.
We thus first describe how the drugs affected overall neuronal
activity in MT.
Spontaneous activity
Gabazine significantly increased the spontaneous activity at the
population level (n  61, p  0.001, signed-rank test; Fig. 2A).
Fifty-six of 76 cells showed increased spontaneous activity when
gabazine was applied, whereas 20 of 76 cells showed reduced
spontaneous activity. Note that these changes did not have to be
significant at the single-cell level, because we only required cells
to show a significant drug effect on either spontaneous activity or
stimulus-driven activity to be included. To outline the cells in
which spontaneous activity was significantly affected by the drug,
we plotted them with a different symbol (black squares) from
those in which spontaneous activity was not significantly affected
(gray circles). Similar effects on spontaneous activity were found
when ACh was applied. ACh significantly increased the sponta-
neous activity (n 58, p 0.001, signed-rank test; Fig. 2). Forty-
two of 58 cells showed increased spontaneous activity when ACh
was applied, whereas 16 of 58 cells showed reduced spontaneous
activity (Fig. 2B). As in Figure 2A, spontaneous activity signifi-
cantly affected by the drug is plotted as a black square, whereas
spontaneous activity not significantly affected by the drug is plot-
ted as a gray circle. Some data points are close to the unity line,
but spontaneous activity was nevertheless significantly affected
by the drug. The large number of trials available to assess spon-
taneous activity yielded significance, despite overall small differ-
ences (2  12  10 trials per drug condition). Overall
spontaneous activity in the absence of drug applicationwas lower
(mean of 2.8 spikes/s) than that reported in other studies (Maun-
sell and Van Essen, 1983; Britten et al., 1993).
Stimulus-driven activity
We analyzed stimulus-driven responses in PD in two separate
response windows, one corresponding to the transient response
(0–150 ms after response onset) and the other to the sustained
response (150–550 ms after response onset). The exact number
of cells that showed increased activity during drug application for
the PD of motion varied marginally between response windows
and different stimulus contrast, so we do not report them indi-
vidually here. They can be deduced from Figure 3. Note that
significant drug effects were assessed by means of a two-factor
ANOVA (see Materials and Methods). This means that the drug
could be effective across all stimulusmotion directions, or only at
a few stimulus directions, which may or may not include the PD.
We therefore assessed the overall p value of the drug effect ob-
tained from the ANOVA, which yields the cells that showed any
drug effect during stimulus presentation, and also performed a
post hoc analysis to determine whether the drug was effective
when the PD was presented. If the former was the case but the
latter not, we use a different symbol in Figure 3, as detailed below.
The plots in Figure 3,A andB, separately show the number of cells
Table 2. Drug-induced ratemodulation (quantified by MIs) for different analysis
timewindows (relative to response onset) and stimulus contrasts
Drug
Stimulus
contrast
Analysis
window
MI (median/
interquartile range)
Significance
(MI group difference)
ACh 25% 0–150 ms 0.104/0.254 p 0.036
Gabazine 25% 0–150 ms 0.179/0.361
ACh 25% 150–550 ms 0.128/0.227 p 0.108
Gabazine 25% 150–550 ms 0.163/0.215
ACh 12.5% 0–150 ms 0.106/0.441 p 0.089
ACh 12.5% 0–150 ms 0.200/0.374
ACh 12.5% 150–550 ms 0.159/0.274 p 0.232
ACh 12.5% 150–550 ms 0.202/0.302
Positive values indicate higher discharge rates during drug application. p values indicate whether the respective MI
distributions were significantly different (rank-sum test).
Table 3. Contrast-induced ratemodulation (quantified by MIs) for different
analysis timewindows (relative to response onset) and for control and
drug-applied conditions
Drug condition
Analysis
window
Contrast MI (median/
interquartile range)
Significance
(MI group difference)
ACh not applied 0–150 ms 0.249/0.265 p 0.797
ACh applied 0–150 ms 0.276/0.269
ACh not applied 150–550 ms 0.183/0.218 p 0.635
ACh applied 150–550 ms 0.145/0.312
Gabazine not applied 0–150 ms 0.223/0.308 p 0.644
Gabazine applied 0–150 ms 0.217/0.377
Gabazine not applied 150–550 ms 0.187/0.235 p 0.284
Gabazine applied 150–550 ms 0.145/0.309
Positive values indicate higher discharge rates when high-contrast stimuli (25%)were presented. p values indicate
whether the respective MI distributions were significantly different (rank-sum test).
16608 • J. Neurosci., November 21, 2012 • 32(47):16602–16615 Thiele et al. • Neuromodulation of Direction Selectivity
that were significantly affected by the drug during stimulus-
driven activity (filled and open squares). Assessment of drug ef-
fects on stimulus-driven activity was done after correcting for
effects of the drug on spontaneous activity (see Materials and
Methods). They also show the (few) cells that were only affected
during spontaneous activity (large gray circles). Finally, the plots
separately show the cells in which a significant drug effect on PD
activity was also found (post hoc test, p  0.05; black squares).
Gabazine and ACh both significantly increased stimulus-driven
activity in the early and late response windows at both contrast
Figure 5. Influence of gabazine and ACh on DIs.A, Time-resolved DIs when gabazinewas not applied (black solid line) andwhen it was applied (black dashed line).B, DI valuesmeasuredwithin
the two response windows and two contrasts when gabazine was applied and when it was not applied. C, Time-resolved DIs when ACh was not applied (black solid line) and when it was applied
(black dashed line). D, DI values measured within the two response windows and two contrasts when ACh was applied and when it was not applied. Left column shows data for 25% stimulus
contrast, and right column shows data for 12.5% stimulus contrast. The small box underneath each time-resolved DI plot shows the p value [log(1/p)] for each time bin (10mswidth) comparing the
DI distribution of drug applied versus not applied (signed-rank test). To account for multiple comparisons, we used FDR correction (seeMaterials andMethods). The dashed line in each p value plot
gives the FDR-corrected significance level of 0.05. Values above this line are significant. p values in B and D indicated whether drug application significantly changed DIs.
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levels tested (p 0.05, signed-rank test; Fig. 3A,B). As described
in Materials and Methods, we did not establish a dose–response
curve for our neurons and the ejection currents did vary between
recordings (see Materials and Methods). The strength of effects
could thus be correlated with the ejection currents used, even if
we aimed formoderate drug effects across the sample of neurons.
Contrary to this suggestion, Figure 4, A and B, demonstrates that
there was no correlation between ejection current and drug effi-
cacy in our dataset (p 0.1, Pearson’s correlation coefficient).
To quantify the differential effect between ACh and gabazine
on stimulus-driven activity, we calculated MIs for the different
time windows, contrasts, and drugs conditions. The means and
SDs of these MIs are listed in Table 2. Gabazine application in-
duced significantly larger response changes in the early response
window at high contrast than ACh did (p  0.036, rank-sum
test). This is illustrated by Figure 4C, in which drug-induced
response MIs for 25% contrast stimuli during the early response
window are shown. No differences in drug efficacy were found at
25% contrast for the late response period or for the 12.5% con-
trast in either response window (Fig. 4C–F).
We used two different contrasts (12.5 and 25%) that were
fixed throughout our study. Although these contrasts may be
saturating for some neurons, we found that they yielded signifi-
cantly different firing rates in the absence of drug application for
the populations of cells (p  0.001, all samples and response
windows, signed-rank test). Specifically, for our cell sample re-
corded with and without ACh, the 25% contrast stimulus re-
sulted in a 66% (median, no ACh) and 76% (median, ACh
applied) increase of firing rates compared with the 12.5% con-
trast stimulus (preferred motion direction; interquartile range,
107 and 105%, respectively) for the early response window. It
resulted in a 44% (median, no ACh) and 29% (median, ACh
applied) increase of firing rates compared with the 12.5% con-
trast stimulus (interquartile range, 63 and 62%, respectively) for
the late response window. The respective numbers for our gaba-
zine cell sample were a 57% increase (no gabazine) and 53%
Figure6. Influence of gabazine andACh on tuningwidth and tuning amplitude. The top two rows showdata relating to gabazine application (row1, tuningwidth; row2, tuning amplitude), and
the bottom two rows show data relating to ACh application (row 3, tuning width; row 4, tuning amplitude). Columns 1 (25% contrast stimuli) and 2 (12.5% contrast stimuli) show data relating to
the early responsewindow, and columns 3 (25% contrast stimuli) and 4 (12.5% contrast stimuli) showdata relating to the late responsewindow. Data obtained in the no-drug condition are plotted
along the x-axis in each subplot, and those obtained with drug applied are plotted along the y-axis in each subplot. p values indicate level of significance for the drug/no-drug comparison
(signed-rank test).
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increase (gabazine applied) (interquartile range, 116 and 132%,
respectively) for the early response window and a 46% increase
(no gabazine) and 33% increase (gabazine applied) (interquartile
range, 74 and 87%, respectively) for the late response window.
We calculatedMI distributions for all these contrast comparisons
and determined whether the contrast MI distributions differed
between drug applied and drug not applied (Table 3). All the
distributions were significantly offset from 0 (p  0.001, rank-
sum test), but theydidnotdiffer significantly fromoneanother (the
smallest p value was  0.285, Wilcoxon’s signed-rank test), which
demonstrates that the drugs were equally effective at 12.5 and 25%
contrast. This pattern was found for both response windows and
bothdrugs. An example of the two contrast MI distributions for
ACh not applied and ACh applied (early response window) is
shown in Figure 4G.
Directional tuning
Gabazine application significantly decreased the DI at 12.5 and
25% contrast (Fig. 5A,B). This effect was significant for the early
response window and the late response window for both contrast
levels (Fig. 5B). ACh did not significantly affect the DI at any
point in time at 12.5 or 25% contrast (Fig. 5C,D).
To further quantify the effects of drug application on direc-
tional tuning, we fitted a wrapped Gaussian to the mean firing
rates (see Materials andMethods), which yielded data relating to
tuning widths (FWHH) and tuning amplitude. Gabazine appli-
cation significantly increased the FWHH
and amplitude for both responsewindows
at both stimulus contrasts (signed-rank
test, for exact p values, see Fig. 6). Con-
versely, ACh application had no signifi-
cant effect on the FWHH in any response
window or at any contrast. However, ACh
significantly increased the tuning ampli-
tude for both response windows at both
stimulus contrasts (signed-rank test, for
exact p values, see Fig. 6).
Note that the number of entries in Fig-
ure 6 does vary and is lower than the re-
ported number of cells included in the
overall analysis. This is because the quality
of fits could vary for the different response
windows and contrasts. To obtain reason-
able tuning estimates, the quality of the fit
had to be acceptable, whereby the vari-
ance accounted for by any drug-related
and no-drug-related fit had to be 70%
(see Materials and Methods).
Activity-matched ACh and gabazine
sample analysis
All the above analyses of effects of gaba-
zine and ACh were based on our entire
sample of cells that passed our inclusion
criteria (see Materials and Methods). Al-
though drug effects between gabazine and
AChonPDactivitywere only significantly
different for the early response window at
25% contrast, the distributions shown in
Figure 4C–F and the values presented in
Table 2 suggest that gabazine resulted
in somewhat stronger increases in firing
rates at the population level than ACh ap-
plication did. We therefore performed the above analyses on
activity-matched samples as described inMaterials andMethods.
Using these matched samples, we found that ACh and gabazine
significantly increased the tuning amplitude at both contrasts
and in both analysis windows (p 0.01, signed-rank test). Only
gabazine significantly increased the FWHH (both analyses win-
dows and both contrasts, all p 0.05, signed-rank test), whereas
ACh did not have an effect in either analysis windows at either
contrast (all p  0.1, signed-rank test). Gabazine significantly
reduced theDI at 12.5 and 25%contrast in both analysis windows
(p  0.01, signed-rank test). For the activity-matched sample,
ACh did not affect the DI at 25 or 12.5% contrast in the early or
late analysis window. Thus, all analyses performed with the
activity-matched samples yield results that are qualitatively and
quantitatively similar to those performed on our entire cell sam-
ple. The differential effects on tuning functions seen between
gabazine and ACh application therefore cannot be accounted for
by larger activity increases induced by gabazine application.
Stimulus discriminability
The above analyses gave insight into directional tuning measures
based on mean responses, but these measures do not provide
insight into neuronal discriminability. To assess the latter, we
calculated neuronal d, which takes differences in mean activity
and the neuronal variability into account. We used the response
associated with PD stimuli as our reference and calculated d for
Figure 7. Influence of gabazine and ACh on neuronal discriminability. The top row shows the results when gabazine was not
applied (black) andwhen itwas applied (gray) for 25% contrast stimuli (solid lines) and 12.5% contrast stimuli (dashed lines). The
bottom row shows the equivalent results for ACh. The left column shows the data for the early response window, and the right
column shows the data for the late response window. x-Axis shows angular difference of stimuli used for d calculation. The
reference was the preferred motion stimulus. Error bars show SEM. p values denote level of significance of factors drug, direction,
contrast, and interaction (if significant) based on three-factor RM-ANOVA.
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all the other directions of motion. This
was done separately for the two response
windows (relative to the response onset of
a neuron, i.e., latency; see Materials and
Methods), for each contrast and for the
drug and no-drug conditions. The out-
come of this analysis is shown in Figure 7.
During the early response period, d val-
ues were overall lower compared with the
late response period. This is most likely
attributable to a response transient that
occurs in some neurons with stimulus
presentation regardless of the direction of
motion. The stimulus transient has mo-
tion energy in opposing stimulus direc-
tions across a range of spatial frequencies,
and thus reduced d values for the early
response period are not surprising. How-
ever, stimulus direction and contrast still
had a significant effect on neuronal d.
Gabazine did not affect neuronal discrim-
inabilityduring theearly response[p0.05,
three-factor repeated-measures (RM)
ANOVA]. ACh increased neuronal dis-
criminabilty in the early response window
for high-contrast but not for low-contrast
stimuli (drug  contrast interaction: p 
0.009, three-factor RM-ANOVA). During
the late period, gabazine application signifi-
cantly reduced d values (p 0.0025, three-
factor RM-ANOVA), i.e., gabazine reduced
the ability of a neuron to discriminate be-
tween preferred and other directions of motion. Conversely, ACh
significantly increased the neuronal d during the late response pe-
riod (p 0.019, three-factor RM-ANOVA), i.e., ACh increased the
ability of a neuron to discriminate between preferred and other di-
rections of motion.
Reliability of neuronal responses (FFs)
Figure 8 shows the time-resolved FFs (relative to the response
onset of the neuron) for PD and APD motion for both drug and
contrast conditions. The solid straight horizontal lines show the
FF during spontaneous activity (50 to 0 ms before stimulus
onset) during the no-drug anddrug conditions. FFswere reduced
after response onset, in line with recent reports (Churchland et
al., 2010); they remained at somewhat higher levels than those
reported from awake monkeys but are similar to those reported
from areaMT in anesthetizedmonkeys (Churchland et al., 2010).
Gabazine significantly increased FFs at 12.5 and 25% contrast
(p  0.001, three-factor ANOVA, drug main effect). There was
no effect of stimulus direction or time after response onset on FFs
at either contrast (p 0.05, three-factor ANOVA). ACh did not
affect FFs at 25 or 12.5% contrast (main effect of drug 0.05,
three-factor ANOVA), none of the other factors had a significant
main effect on FFs, and there were no interactions between any
of the effects. Our selection criterion required neurons to be
significantly affected by the drug application. This selection was
based on firing rates. It could be the case that the drug does not
affect the firing rate of a neuron but still alters the FF. To account
for this possibility, we included the (few) neurons that were not
affected by the drug in the analysis. The effect of the drugs on FFs
did not change when these neurons were included. Gabazine still
resulted in a significant increase in FF at both contrasts (p 0.01,
three-factor ANOVA, drug main effect). ACh still did not alter
the FF when neurons not significantly affected by drug applica-
tion were included (p 0.05, three-factor ANOVA).
Noise correlation between simultaneously recorded neurons
We measured noise correlation between simultaneously re-
corded neurons as a function of motion direction relative to PD
and as a function of drug application. We included pairs of neu-
rons into the analysis if the PD of the two neurons did not differ
by 45°, i.e., both neurons preferred more or less the same di-
rection of motion. We did not find a significant main effect of
contrast for any of our datasets (p  0.2, three-factor ANOVA,
main effect of contrast) and thus pooled across different con-
trasts. Figure 9 shows the results for the two different drugs
applied. Gabazine significantly increased noise correlations
(significant main effect of drug, p  0.001, three-factor
ANOVA). We did not find a main effect of direction (p  0.74,
three-factor ANOVA) or an interaction between direction and
drug (p 0.15, three-factor ANOVA) in our dataset. Conversely,
ACh significantly reduced noise correlations (significant main
effect of drug, p 0.001, three-factor ANOVA). Stimulus direc-
tion had no effect on noise correlations (p  0.85, three-factor
ANOVA), and there was no significant interaction between di-
rection and drug (p  0.91, three-factor ANOVA). In line with
the drug efficacy argument made in the FF section, we recalcu-
lated noise correlations with neurons included that did not show
significant drug-induced alterations of firing rates. The addi-
tional analysis did not change the outcome, i.e., ACh still signif-
icantly reduced noise correlations (p 0.001), whereas Gabazine
increased it (p 0.001). Thus, gabazine increased noise correla-
Figure 8. Influence of gabazine and ACh on response reliability. Response reliability (FF) was measured in windows of 50 ms
length, shifted in steps of 50 ms after response onset (x-axis). The top row shows the results when gabazine was not applied and
when it was applied for stimuli moving in PD (black lines) and APD (gray lines). The bottom row shows the equivalent results for
ACh. The left columnshows thedata for 25%contrast stimuli, and the right columnshows thedata for 12.5%contrast stimuli. Solid
lines show data for the no drug condition, and dashed lines show data for the drug condition. Error bars show SEM. The black
straight horizontal lines show spontaneous FF and SEM (solid line, drug not applied; dotted line, drug applied).
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tion at all contrasts and for all directions, whereas ACh reduced
noise correlations at all contrasts and for all directions.
Discussion
Here we report the effects of ACh and gabazine application on
MT neuron firing rates, tuning properties, response reliability,
and rate correlations. Gabazine and ACh both increased
stimulus-driven firing rates but had very different effects on neu-
ronal tuning, discriminability, response reliability, and neuronal
correlations. Gabazine deteriorated tuning, as assessed by DI,
tuning width, and discriminability. Conversely, ACh had no neg-
ative effects on DI, tuning width, and improved discriminability.
Gabazine resulted in reduced response reliability for PD andAPD
motion direction stimuli. ACh did not result in reduced response
reliability when PD motion stimuli were presented. Gabazine
application increased noise correlations, whereas ACh applica-
tion decreased noise correlations. Thus, relatively similar in-
creases in firing rates by gabazine and ACh can translate into very
different effects on other response characteristics.
Interaction with anesthesia
Here we recorded the effects of ACh and gabazine application on
tuning functions inMTunder anesthesia.We decided to perform
these experiments in the anesthetized animal, because this prep-
aration allows investigating more stimulus conditions with and
without drug applied than is feasible in the awake animal, espe-
cially in animals performing attention-demanding tasks. How-
ever, anesthesia interacts with the cholinergic and GABAergic
systems (Anthony et al., 1989; Yamakura et al., 2001; Tassonyi et
al., 2002), whichmay have implications for our results, especially
regarding our findings in relation to noise correlations and FFs. If
halothane induced a synchronized brain state (Harris and Thiele,
2011), then noise correlations might be increased overall, and
alterations seen with, for example, ACh might be much larger
than what would occur in awake animals. However, the noise
correlations in the absence of drugs were relatively close to those
reported in awake animals (Zohary et al., 1994; Thiele and Hoff-
mann, 2008). It will still be important to perform similar drug-
related experiments in the awake preparation, but, based on our
experience in V1, these have to be restricted to fewer stimulus
conditions, whereby detailed tuning properties are much harder
to investigate than under anesthesia.
Directional tuning
GABAergic mechanisms contribute to directional tuning in V1
(Sillito, 1977; Sato et al., 1995; Crook et al., 1998; Murthy and
Humphrey, 1999; Roerig and Kao, 1999). It was argued that neu-
rons in macaque area MT inherit their direction selectivity from
neurons in areas V1, V2, andV3 (Movshon andNewsome, 1996),
because cells that project to MT are already directionally se-
lective. Blocking GABAA receptors in area MT with bicuculline-
methiodide (BMI) nevertheless demonstrated thatMT cells often
generate directional selectivity de novo (Thiele et al., 2004). BMI
reduced direction selectivity during the early response period,
whereas it was preserved in later response periods. In line with
these findings, we show here that gabazine reduced directional
tuning ofMTneurons. Thiele et al. (2004) also reported that BMI
application increased the tuning width ofMT neurons, which we
replicate using gabazine. Despite these similarities, some of the
gabazine effects differed from those reported previously (Thiele
et al., 2004). First, effects on DI were smaller. Second, we did not
see the main changes on DI to occur during the initial response
period but also during the later response period. Although the
differences are mostly quantitative, they are still noteworthy. Thiele
at al. (2004) used BMI, which also blocks small-conductance
calcium-activated potassium channels (Khawaled et al., 1999),
thereby affecting the slow afterhyperpolarization.Gabazine is highly
specific forGABAAreceptors, and thedifferences foundbetween this
study and the study by Thiele et al. (2004) could thus be attributable
to differentially affecting SK channels.
Based on previous studies in V1 (Sillito and Kemp, 1983; Sato
et al., 1987; Murphy and Sillito, 1991), we predicted that ACh
application would result in sharpened directional tuning in MT
neurons. However, we found no effect of ACh application on
either the DI or tuning width.We found, however, a significantly
increased tuning amplitude. The latter was also found with gaba-
zine application. Thus, increased stimulus-driven responses,
which occurred with gabazine and ACh application, resulted in
reduced directional tuning when GABAA transmission was
blocked but in unchanged directional tuning when cholinergic
receptors were activated. Because ACh did not affect the response
variability when motion in PD was presented, the increased tun-
ing amplitude translated into increased neuronal discriminabil-
ity. The latter was not found when gabazine was applied, most
likely because gabazine strongly increased response variability,
which deteriorates the signal.
ACh contributes to attentional mechanisms (Gill et al., 2000;
Parikh et al., 2007; Herrero et al., 2008; Parikh and Sarter, 2008;
Deco and Thiele, 2009, 2011), and the effects seen on directional
tuning with ACh application are similar to those reported when
Figure 9. Influence of gabazine (A) and ACh (B) on noise correlations for stimuli moving in
differentdirections relative toPD.Gray lines anderror bars showthenoise correlationswhen the
drugwas applied, and black lines and error bars show the noise correlations when no drugwas
applied. Noise correlation data for the different contrasts are pooled, because there was no
difference between 25 and 12.5% contrast stimuli. p values denote whether drug application
had a significant effect on noise correlations. Error bars show SEM.
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attention is directed to the RF of the neuron under study, namely
multiplicative changes in response amplitude without affecting
tuning width (McAdams and Maunsell, 1999; Martinez-Trujillo
and Treue, 2004; Busse et al., 2008; Womelsdorf et al., 2008).
These results are not simply the consequence of increased overall
activity, because GABAA receptor blockade had very different
effects (e.g., increased tuning width). This suggests that atten-
tional modulation affects excitatory and inhibitory circuits
equally, ensuring that excitatory drive is balanced by appropriate
inhibition, as suggested by recent models of attention (Ghose,
2009; Lee and Maunsell, 2009; Reynolds and Heeger, 2009).
Response reliability
Application of gabazine resulted in reduced response reliability,
whereas application of ACh had little effect on response reliabil-
ity. Previous studies in V4 (Mitchell et al., 2007, 2009) have ob-
served increased response reliability with attention. Although
this was also seen after basal forebrain stimulation in anesthetized
rats, which increases ACh drive cortically and subcortically
(Goard and Dan, 2009), the effects in V1 were attributable to
mechanisms along the subcortical processing pathway (Goard
and Dan, 2009). Thus, it appears that ACh does not contribute
directly at the cortical level to attention-induced improvements
of response reliability. Increased response reliability with atten-
tion might be attributable to glutamatergic (feedback) drive,
which could stabilize the local network and make it more resis-
tant to slow response fluctuations induced by unspecific inputs.
Noise correlations
Despite having similar effects on firing rates, gabazine and ACh
application had opposite effects on noise correlations in MT.
Gabazine increased noise correlations, whereas ACh reduced
noise correlations. Reduced noise correlation was also reported
in V1 after basal forebrain stimulation in anesthetized rats, and
these effects were mediated by muscarinic receptors within V1
(Goard and Dan, 2009). Attention reduces noise correlations in
V4 (Cohen and Maunsell, 2009; Mitchell et al., 2009), and the
results reported here and those reported by Goard and Dan
(2009) suggest that ACh might be an important contributor to
this attention-induced noise correlation reduction. To assert this,
it will be necessary to record from multiple neurons while ani-
mals perform attention-demanding tasks and determine noise
correlations with and without cholinergic blockade.
Conclusions
In summary, gabazine and ACh application both resulted in in-
creased firing rates but had very different effects on directional
tuning functions, discriminability, response reliability, and noise
correlations. Some, but not all, of the effects seen with ACh ap-
plication were reminiscent of those reported in animals perform-
ing attention-demanding tasks. This further supports the notion
that AChmakes important contributions to attentional modula-
tion, but it also highlights that our understanding of the mecha-
nisms of attention is still very incomplete.
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